M. List

发表

Cancer during adolescence.

M. List, C. Ritter-Sterr, S. Lansky, 1991, Pediatrician.

Evaluations of quality of life and organ function.

M. List, S. Bilir, 2004, Seminars in oncology.

Functional outcomes in head and neck cancer.

M. List, S. Bilir, 2004, Seminars in radiation oncology.

How D o H ead a nd N eck C ancer P atients P rioritize Treatment O utcomes B efore I nitiating T reatment

E. Vokes, D. Haraf, L. Colangelo, 2000 .

The importance of quality-of-life measurements in oncology.

J. Villano, E. Vokes, M. List, 2002, Clinical lung cancer.

Swallowing function in patients with head and neck cancer prior to treatment.

R. Weichselbaum, E. Vokes, D. Haraf, 2000, Archives of otolaryngology--head & neck surgery.

Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

K. Ang, G. Weinstein, Snehal G. Patel, 2006 .

Cohort profile: the ChicagO Multiethnic Prevention and Surveillance Study (COMPASS)

F. Jasmine, M. Kibriya, H. Ahsan, 2020, BMJ Open.

A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).

A. Garden, K. Ang, R. Weber, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-agent versus combination chemotherapy in advanced non-small cell lung cancer (NSCLC): A CALGB randomized trial of efficacy, quality of life, and cost-effectiveness

C. Desch, J. Herndon, Mark R. Green, 2001 .

The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.

Christopher U. Jones, A. Garden, R. Weber, 2021, Journal of geriatric oncology.

Genetic Testing of African Americans for Susceptibility to Inherited Cancers

S. Cummings, M. List, A. Matthews, 2000 .

Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients

E. Vokes, J. Logemann, B. Pauloski, 2004, Head & neck.

Longitudinal assessment of quality of life in laryngeal cancer patients

J. Logemann, B. Pauloski, L. Colangelo, 1996, Head & neck.

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.

R. Weichselbaum, E. Vokes, D. Haraf, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.

A. Rademaker, R. Weichselbaum, E. Vokes, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

You're never too old: a cancer education and risk reduction program for the elderly.

M. H. Maskay, M. List, D. Banik, 1999, Journal of cancer education : the official journal of the American Association for Cancer Education.

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.

R. Schilsky, E. Vokes, J. Kugler, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN).

D. Cella, E. Vokes, M. Kane, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers

A. Rademaker, A. Rademaker, J. Logemann, 2001, International journal of cancer.

Randomized Phase II Study of Paclitaxel ( 1-Hour Infusion ) , Fluorouracil , Hydroxyurea , and Concomitant Twice Daily Radiation with or without Erythropoietin for Advanced Head and Neck Cancer

A. Rademaker, R. Weichselbaum, E. Vokes, 2003 .

Concomitant I nfusional P aclitaxel a nd F luorouracil, O ral Hydroxyurea, a nd H yperfractionate d R adiation f or L ocally Advanced S quamous H ead a nd N eck C ancer

A. Rademaker, R. Weichselbaum, E. Vokes, 2001 .

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.

R. Weichselbaum, E. Vokes, D. Haraf, 2001, Cancer journal.

Use of IMRT to reduce toxicity from concomitant radiation and chemotherapy for advanced head and neck cancers

A. Rademaker, J. Logemann, A. Mahadevan, 2001 .

The involvement of low literate elderly women in the development and distribution of cancer screening materials

L. Lacey, M. List, D. Burton, 1994 .

A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores

D. Cella, S. Yount, R. Bode, 2007, Quality of Life Research.

The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity

E. Vokes, P. Mumby, M. List, 1996, Cancer.

A performance status scale for head and neck cancer patients

M. List, S. Lansky, C. Ritter‐Sterr, 1990, Cancer.

Toward the development of a play performance scale for children (PPSC)

M. List, S. Lansky, Michael E. Cohen, 1985, Cancer.

Quality of life and late toxicities in head and neck cancer.

M. List, J. Stracks, John Stracks, 2003, Cancer treatment and research.

State Anxiety and Cancer-Specific Anxiety in Survivors of Breast Cancer

N. Rothrock, G. Fleming, M. List, 2004 .

How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

E. Vokes, D. Haraf, L. Colangelo, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.

E. Vokes, D. Haraf, K. Stenson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.

K. Ang, G. Weinstein, D. Pfister, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.

C. Desch, R. Lilenbaum, M. List, 1999, Seminars in oncology.

Psychosocial consequences of cure

M. List, S. Lansky, C. Ritter‐Sterr, 1986, Cancer.

Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer

E. Vokes, D. Haraf, R. Mick, 1997, Quality of Life Research.

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck

E. Vokes, D. Haraf, M. Kies, 2002, Cancer.

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.

R. Weichselbaum, E. Vokes, D. Haraf, 2006, International journal of oncology.

Is patient travel distance associated with survival on phase II clinical trials in oncology?

E. Lamont, E. Vokes, J. Dignam, 2003, Journal of the National Cancer Institute.

The measurement of performance in childhood cancer patients

M. List, S. Lansky, L. Lansky, 1987, Cancer.

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

J. Holland, C. Desch, J. Herndon, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

E. Vokes, D. Huo, E. Cohen, 2005, Clinical Cancer Research.

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.

A. Rademaker, R. Weichselbaum, E. Vokes, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Absence of major depressive disorder in female cancer patients.

G. Wilbanks, M. List, S. Lansky, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.

E. Vokes, L. Mell, D. Haraf, 2008, Archives of otolaryngology--head & neck surgery.

Applying a conceptual model for examining health‐related quality of life in long‐term breast cancer survivors: CALGB study 79804

E. Winer, C. Shapiro, E. Paskett, 2008, Psycho-oncology.

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.

A. Rademaker, R. Weichselbaum, E. Vokes, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive induction chemotherapy followed by concomitant chemoradiotherapy in the management of locoregionally advanced carcinoma of the pyriform sinus.

R. Weichselbaum, E. Vokes, D. Haraf, 2003 .

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.

R. Weichselbaum, E. Vokes, D. Haraf, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Educating African-American men about prostate cancer: impact on awareness and knowledge.

G. Chodak, S. Wilkinson, M. List, 2003, Urology.

Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck

M. List, John Stracks, John Stracks, 2000, Current opinion in oncology.

Patients' priorities among treatment effects in head and neck cancer: Evaluation of a new assessment tool

C. Stocking, K. Stenson, H. Sharp, 1999, Head & neck.

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

E. Vokes, K. Mouw, D. Haraf, 2012, Oral oncology.

Head and Neck Cancer Quality of Life Instruments

M. List, 2009 .

Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.

Xi Xi, Joseph K Salama, E. Vokes, 2010, Archives of otolaryngology--head & neck surgery.

Complementary and alternative medicine use among breast cancer survivors.

D. Huo, G. Fleming, M. List, 2007, Journal of alternative and complementary medicine.

Sexual Functioning and Head and Neck Cancer

E. Vokes, M. List, A. Siston, 1998 .

Induction Chemotherapy followed by Concomitant TFHX Chemoradiotherapy with Reduced Dose Radiation in Advanced Head and Neck Cancer

R. Weichselbaum, E. Vokes, A. Argiris, 2003 .

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.

E. Vokes, D. Haraf, E. Cohen, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Gefitinib 250 mgDaily in Patientswith Recurrent and / orMetastatic Squamous Cell Carcinoma of the Head and Neck

E. Vokes, D. Huo, M. Kane, 2005 .

American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.

G. Weinstein, W. Mendenhall, L. Harrison, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life (QL) and performance outcome in survivors of concomitant chemoradiotherapy protocols for head and neck cancer (HNC) (Meeting abstract).

R. Weichselbaum, E. Vokes, D. Haraf, 1997 .

The effect of age on outcome in prospective, phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- chemotherapy in locally advanced (LA) head and neck cancer (HNC).

Christopher U. Jones, A. Garden, R. Weber, 2015 .